Health and Fitness Health and Fitness
Fri, February 15, 2013
Thu, February 14, 2013
Wed, February 13, 2013
Tue, February 12, 2013
Mon, February 11, 2013
Sun, February 10, 2013
Fri, February 8, 2013
Thu, February 7, 2013
Wed, February 6, 2013
Tue, February 5, 2013
Mon, February 4, 2013
Sun, February 3, 2013
Sat, February 2, 2013
Fri, February 1, 2013
Thu, January 31, 2013
Wed, January 30, 2013
Tue, January 29, 2013
[ Tue, Jan 29th 2013 ] - Market Wire
AtheroNova Launches New Website
Mon, January 28, 2013

China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation


//health-fitness.news-articles.net/content/2013/ .. letion-of-corporate-structure-consolidation.html
Published in Health and Fitness on Thursday, February 7th 2013 at 4:16 GMT by Market Wire   Print publication without navigation


China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation -- HONG KONG, Feb. 7, 2013 /PRNewswire-FirstCall/ --

HONG KONG, Feb. 7, 2013 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: [ CO ]) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced the completion of the previously announced transaction with Cordlife Services (S) Pte. Ltd., a subsidiary of the Company's strategic affiliate, Cordlife Limited (CBB.AU) ("Cordlife"), a cord blood and tissue banking services provider listed on the Australian Securities Exchange.  As a result of the transaction, CCBC's effective equity interest in Shandong Province Qilu Stem Cells Engineering Co., Ltd. ("Qilu"), the operator of the Shandong Cord Blood Bank, has increased from approximately 19.9% to 24.0%, further extending the Company's presence in the Shandong market. The transaction was first announced on December 6, 2012.

For further details of the transaction, please refer to CCBC's Report on Form 6-K filed on December 6, 2012 with the US Securities and Exchange Commission, which contains copies of the related documents and is available at [ http://www.sec.gov ].

About China Cord Blood Corporation

China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses.  Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today.  China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit the Company's website at [ http://www.chinacordbloodcorp.com ].    

For more information, please contact:

China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: [ ir@chinacordbloodcorp.com

ICR, Inc.
Mr. Rob Koepp
Tel: (+86) 10-6583-7516 or (646) 405-5185
Email: [ robert.koepp@icrinc.com ]

SOURCE China Cord Blood Corporation



RELATED LINKS
[ http://www.chinacordbloodcorp.com ]

Publication Contributing Sources